Why Venus Concept Shares Are Trading Higher By Over 63%? Here Are 58 Stocks Moving In Wednesday's Mid-Day Session

Gainers

• Sintx Technologies, Inc. SINT shares climbed 81.4% to $13.55 after the company was awarded Phase I contract for $150,000 from the Missile Defense Agency for electrochemical machining.
• Venus Concept Inc. VERO gained 63.3% to $0.4122 after the company announced it received a 510(k) clearance from the FDAto market its AI.ME next generation robotic technology for fractional skin resurfacing.
• Laser Photonics Corporation LASE jumped 40% to $2.1499 after the company announced it received an order from the largest glass manufacturer in North America.
• Cenntro Electric Group Limited CENN rose 33.6% to $0.3561. Cenntro started shipments of LS260 and LS100 vans to European Markets.
• F-star Therapeutics, Inc. FSTX gained 29.9% to $5.59.
• Rekor Systems, Inc. REKR jumped 28% to $0.7622. Rekor announced financing to solidify cash position and accelerate business growth and technology development.
• Mobile Global Esports Inc. MGAM jumped 25% to $0.7885. Maxim Group initiated coverage on Mobile Global Esports with a Buy rating and announced a price target of $1.5.
• Kineta, Inc. KA surged 25% to $4.70.
• Blue Star Foods Corp. BSFC gained 23.7% to $0.5319.
• Appreciate Holdings, Inc. SFR rose 22.6% to $1.68.
• BeyondSpring Inc. BYSI gained 22.5% to $2.07.
• Erayak Power Solution Group Inc. RAYA gained 22.1% to $3.2955 after jumping over 47% on Tuesday.
• Ecoark Holdings, Inc. ZEST rose 21.4% to $0.34.
• Grove Collaborative Holdings, Inc. GROV rose 21% to $0.2476. Grove announced receipt of continued listing standards notice from NYSE.
• Akari Therapeutics, Plc AKTX gained 20.6% to $0.5347.
• CalAmp Corp. CAMP gained 20.1% to $4.12 after the company reported better-than-expected Q3 sales results.
• DatChat, Inc. DATS surged 19.4% to $0.4211.
• Zymeworks Inc. ZYME rose 18.6% to $8.40. Jazz Pharmaceuticals and Zymeworks announced that Jazz has exercised option to continue exclusive development and commercialization rights to Zanidatamab.
• Evelo Biosciences, Inc. EVLO jumped 18.5% to $1.73.
• Pagaya Technologies Ltd. PGY gained 18.4% to $0.7862.
• Altimmune, Inc. ALT gained 18.2% to $14.07. Altimmune announced topline results from its 24-week (12-week extension) trial of pemvidutide in subjects with Non-Alcoholic Fatty Liver Disease (NAFLD).
• Forian Inc. FORA climbed 18.1% to $2.5750. New York has selected Forian's Biotrack as the State's Cannabis Seed to sale track and trace system.
• Adaptive Biotechnologies Corporation ADPT gained 17.7% to $8.35 after Piper Sandler upgraded the stock from Neutral to Overweight and raised its price target from $7.5 to $14.
• Mereo BioPharma Group plc MREO surged 16.2% to $0.6160.
• Avaya Holdings Corp. AVYA gained 14.6% to $0.2386.
• NIKE, Inc. NKE rose 13.9% to $117.51 after the company reported better-than-expected results for its second quarter on Tuesday.
• TransCode Therapeutics, Inc. RNAZ rose 13.2% to $0.3751 after dropping 27% on Tuesday.
• Nine Energy Service, Inc. NINE gained 12.7% to $11.89.
• Six Flags Entertainment Corporation SIX surged 12.3% to $23.50 after Land & Buildings issued a presentation highlighting an opportunity to unlock substantial real estate value at Six Flags. Land & Buildings is approximately a 3% shareholder of Six Flags.
• Butterfly Network, Inc. BFLY shares gained 11.1% to $2.4550. Butterfly Network recently completed successful deployment of 500 Butterfly iQ+ devices and training of 500+ healthcare workers across 224 facilities in Kenya.
• 374Water, Inc. SCWO jumped 10.8% to $2.77.
• Energy Focus, Inc. EFOI rose 7.6% to $0.3434 after declining 11% on Tuesday. Energy Focus, last month, posted a Q3 loss of $0.29 per share.
• FedEx Corporation FDX rose 4% to $170.79. FedEx posted upbeat earnings for its second quarter, while sales missed expectations. The company also said it sees FY23 earnings of $13.00 to $14.00 per share, versus analysts’ estimates of $14.08 per share.

Losers

• Pingtan Marine Enterprise Ltd. PME shares fell 100% to $0.0001.
• Meiwu Technology Company Limited WNW dropped 78% to $0.4099.
• Core Scientific, Inc. CORZ shares dipped 50.5% to $0.1026 after the company filed for Chapter 11 bankruptcy.
• IceCure Medical Ltd ICCM fell 39.8% to $1.5650. IceCure reported pricing of 8,787,880 share public offering at $1.65 per share.
• Celyad Oncology SA CYAD fell 37.4% to $0.6516 after the company reported it has decided to discontinue the development of its remaining clinical program CYAD-211.
• WeTrade Group, Inc. WETG declined 25.7% to $0.2860.
• Singularity Future Technology Ltd. SGLY dropped 23.6% to $0.5599.
• Vivos Therapeutics, Inc. VVOS fell 20.7% to $0.42 after posting a loss for the third quarter.
• Lipella Pharmaceuticals Inc. LIPO fell 20.6% to $3.7399.
• UTime Limited UTME fell 20% to $0.9998.
• Ostin Technology Group Co., Ltd. OST dropped 18.9% to $0.7773.
• Quotient Limited QTNT fell 17.8% to $0.2334.
• Athenex, Inc. ATNX fell 17% to $0.1327. Athenex announced Quantum Leap Healthcare Collaborative reported a trial result of I-SPY2 trial for oral paclitaxel in combination with PD-1 and carboplatin in neoadjuvant breast cancer.
• Magenta Therapeutics, Inc. MGTA dipped 15.9% to $0.33. BTIG maintained Magenta Therapeutics with a Buy and lowered the price target from $6 to $3.
• Caravelle International Group CACO dropped 15.2% to $1.79 after dropping 57% on Tuesday.
• Rite Aid Corporation RAD shares fell 13.9% to $11.89 after the company reported results for its third quarter.
• Lion Group Holding Ltd. LGHL fell 13.5% to $1.2450.
• Surrozen, Inc. SRZN dropped 13.4% to $0.43.
• GEE Group, Inc. JOB fell 12.6% to $0.5661 after the company reported worse-than-expected Q4 sales results.
• Calavo Growers, Inc. CVGW dropped 11.6% to $29.92 after the company reported worse-than-expected Q4 EPS and sales results.
• BlackBerry Limited BB fell 7.8% to $3.82 after the company reported Q4 earnings results.
• Lanvin Group Holdings Limited LANV dropped 7.8% to $6.76.
• Cosmos Health Inc. COSM fell 7.1% to $8.14 after gaining 15% on Tuesday. Cosmos Health recently announced pricing of a $32.5 million registered direct offering and concurrent private placement priced at-the-market.
• Terns Pharmaceuticals, Inc. TERN fell 6.6% to $7.89 after the company reported pricing of $75 million public offering.
• Pebblebrook Hotel Trust PEB fell 5.2% to $13.66 after the company lowered its FY22 FFO per share guidance.

Read This Next: Bitcoin Edges Higher But Remains Below This Key Level; Helium Emerges As Top Gainer